Skip to main content

Advertisement

Log in

Early psychosis research at Orygen, The National Centre of Excellence in Youth Mental Health

  • Invited Review
  • Published:
Social Psychiatry and Psychiatric Epidemiology Aims and scope Submit manuscript

Abstract

Background

Specialised early intervention (SEI) programs have offered individuals with psychotic disorders and their families new hope for improving illness trajectories and outcomes. The Early Psychosis Prevention and Intervention Centre (EPPIC) was one of the first SEI programs developed in the world, providing services for young people experiencing their first episode of psychosis.

Methods

We conducted a narrative synthesis of controlled and uncontrolled studies that have been conducted at EPPIC.

Discussion

The history of the EPPIC model is first described. This is followed by a discussion of clinical research emerging from EPPIC, including psychopharmacological, psychotherapeutic trials and outcome studies. Neurobiological studies are also described. Issues pertaining to the conduct of clinical research and future research directions are then described. Finally, the impact of the EPPIC model on the Australian environment is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. McGorry PD, Edwards J (1998) The feasibility and effectiveness of early intervention in psychotic disorders: the Australian experience. Int Clin Psychopharmcol 13(supp 1):S47–S52

    Article  Google Scholar 

  2. Edwards J, McGorry PD (2002) Implementing early intervention in psychosis: a guide to establishing early psychosis services. Martin Dunitz Ltd, London

    Book  Google Scholar 

  3. McGorry PD (2015) Early intervention in psychosis: obvious, effective, overdue. J Nerv Ment Dis 203:310–318

    Article  PubMed Central  PubMed  Google Scholar 

  4. Phillips LJ, Leicester SB, O’Dwyer LE, Francey SM, Koutsogiannis J, Abdel-Baki A, Kelly D, Jones S, Vay C, Yung AR, McGorry PD (2002) The PACE clinic: identification and management of young people at ‘ultra’ high risk of psychosis. Psychiatr Pract 8:255–269

    Article  Google Scholar 

  5. Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, McGorry PD (2003) Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group. Schizophr Res 60:21–32

    Article  PubMed  Google Scholar 

  6. Yung AR, Phillips LJ, Yuen HP, McGorry PD (2004) Risk factors for psychosis in ultra high-risk group: psychopathology and clinical features. Schizophr Res 67:131–142

    Article  PubMed  Google Scholar 

  7. Phillips LJ, Yung AR, McGorry PD (2000) Identification of young people at risk of psychosis: validation of personal assessment and crisis evaluation clinic intake criteria. Aust N Z J Psychiatry 34:S164–S169

    Article  PubMed  Google Scholar 

  8. Yung A, McGorry PD, McFarlane CA, Patton GC (1995) The PACE clinic: development of a clinical service for young people at high risk of psychosis. Australas Psychiatry 3:345–349

    Article  Google Scholar 

  9. Yung A, McGorry PD, McFarlane CA, Jackson H, Patton GC, Rakkar A (1996) Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull 22:283–303

    Article  CAS  PubMed  Google Scholar 

  10. McGorry PD, Yung A, Phillips LJ (2003) The “close in” or ultra-high-risk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder. Schizophr Bull 29:771–790

    Article  PubMed  Google Scholar 

  11. Yung AR, Yuen HP, Berger G, Francey S, Hung TC, Nelson B, Phillips L, McGorry P (2007) Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull 33:673–681

    Article  PubMed Central  PubMed  Google Scholar 

  12. Nelson B, Yuen HP, Wood SJ, Lin A, Spiliotacopoulos D, Bruxner A, Broussard C, Simmons M, Foley DL, Brewer WJ, Francey SM, Amminger GP, Thompson A, McGorry PD, Yung AR (2013) Long-term follow-up of a group at ultra high risk (“prodromal”) for psychosis: The PACE 400 study. JAMA Psychiatry 70:793–802

    Article  PubMed  Google Scholar 

  13. Wiltink S, Velthorst E, Nelson B, McGorry PM, Yung AR (2015) Declining transition rates to psychosis: the contribution of potential changes in referral pathways to an ultra-high-risk service. Early Interv Psychiatry 9:200–206

    Article  PubMed  Google Scholar 

  14. Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ, Yung AR, Bullmore ET, Brewer WJ, Soulsby B, Desmond P, McGuire PK (2003) Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 361:281–288

    Article  PubMed  Google Scholar 

  15. McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, Germano D, Bravin J, McDonald T, Blair A, Adlrd S, Jackson H (2002) Randomized controlled trial of interventions designed to reduce the risk of progression to first episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 59:921–928

    Article  PubMed  Google Scholar 

  16. Phillips LJ, McGorry PD, Yuen HP, Ward J, Donovan K, Kelly D, Francey SM, Yung AR (2007) Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis. Schizophr Res 96:25–33

    Article  PubMed  Google Scholar 

  17. Phillips LJ, Nelson B, Yuen HP, Francey SM, Simmons M, Stanford C, Ross M, Kelly D, Baker K, Conus P, Amminger GP, Trumpler F, Yun Y, Lim McNab C, Yung A, McGorry PD (2009) Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics. Aust N Z J Psychiatry 43:818–829

    Article  PubMed  Google Scholar 

  18. Yung AR, Phillips LJ, Nelson B, Francey SM, Yuen HP, Simmons MB, Ross ML, Kelly D, Baker K, Amminger GP, Berger G, Thompson AD, Thampi A, McGorry PD (2011) Randomized controlled trial of intervention for young people at ultra high risk for psychosis: 6-month analysis. J Clin Psychiatry 72:430–440

    Article  PubMed  Google Scholar 

  19. McGorry PD, Nelson B, Phillips LJ, Yuen HP, Francey SM, Thampi A, Berger GE, Amminger GP, Simmons MB, Kelly D, Thompson AD, Yung AR (2013) Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve month outcomes. J Clin Psychiatry 74:349–356

    Article  CAS  PubMed  Google Scholar 

  20. Pantelis C, Yucel M, Wood SJ, Velakoulis D, Sun D, Berger G, Stuart GW, Yung AR, Phillips LJ, McGorry P (2005) Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr Bull 31(3):672–696

    Article  PubMed  Google Scholar 

  21. Berger GE, Wood SJ, Ross M, Hamer CA, Wellard RM, Pell G, Phillips L, Nelson B, Amminger GP, Yung AR, Jackson GD, Velakoulis D, Pantelis C, Manji H, McGorry PD (2012) Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis: a longitudinal MRI/MRS study. Curr Pharm Des 18:570–575

    Article  CAS  PubMed  Google Scholar 

  22. Markulev C, McGorry PD, Nelson B, Yuen HP, Schaefer M, Yung AR, Thompson A, Berger G, Mossaheb N, Schlögelhofer M, Smesny S, de Haan L, Riecher-Rössler A, Nordentoft M, Chen EY, Verma S, Hickie I, Amminger GP (2015) NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders. Early Interv Psychiatry. doi:10.1111/eip.12260

  23. Amminger GP, Schafer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, Mackinnon A, McGorry PD, Berger GE (2010) Long-chain {omega}-3 fatty acids for indicated prevention of psychotic disorders: a randomized placebo-controlled trial. Arch Gen Psychiatry 67(2):146–154. doi:10.1001/archgenpsychiatry.2009.192

    Article  CAS  PubMed  Google Scholar 

  24. McGlashan T (1999) Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course? Biol Psychiatry 46:899–907

    Article  CAS  PubMed  Google Scholar 

  25. Birchwood M, Connor C, Lester H, Patterson P, Freemantle N, Marshall M, Fowler D, Lewis S, Jones P, Amos T, Everard L, Singh SP (2013) Reducing duration of untreated psychosis: care pathways to early intervention in psychosis services. Br J Psychiatry 203:58–64

    Article  PubMed  Google Scholar 

  26. McGorry PD (1995) A treatment-relevant classification of psychotic disorders. Aust N Z J Psychiatry 29:555–558

    Article  CAS  PubMed  Google Scholar 

  27. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T (2005) Association between duration of untreated psychosis and outcome in cohorts of first-episode patients. Am J Psychiatry 157:1183–1188

    Google Scholar 

  28. Malla A, Bechard-Evans L, Joober R, King S, Albadi S (2006) Understanding the complexities of delay in treatment of psychosis and relevance for early detection interventions. Schizophr Res 86(Supp 1):S40

    Article  Google Scholar 

  29. Lincoln TM (1995) Who cares? Pathways to psychiatric care for young people experiencing a first episode of psychosis. Psychiatr Serv 46:1166–1171

    Article  CAS  PubMed  Google Scholar 

  30. McGorry PD (2000) Evaluating the importance of reducing the duration of untreated psychosis. Aust N Z J Psychiatry 34:145–149

    Article  Google Scholar 

  31. Apeldoorn SY, Sterk B, van den Heuvel ER, Schoevers RA, Islam MA, Bruggeman R, Cahn W, deHaan L, Kahn RS, Meijer CJ, Myin-Germeys I, van Os J, Wiersma D (2014) Factors contributing to the duration of untreated psychosis. Schizophr Res 158:76–81

    Article  CAS  PubMed  Google Scholar 

  32. Polari A, Lavoie S, Sarrasin P, Pellanda V, Cotton S, Conus P (2011) Duration of untreated psychosis: a proposition regarding treatment definition. Early Interv Psychiatry 5:301–308

    Article  PubMed  Google Scholar 

  33. Carbone S, Harrigan SM, McGorry PD, Curry C, Elkins K (1999) Duration of untreated psychosis and 12-month outcome in first-episode psychosis: the impact of treatment approach. Acta Psychiatr Scand 100:96–104

    Article  CAS  PubMed  Google Scholar 

  34. McGorry PD, Edwards J, Mihalopoulos C, Harrigan SM, Jackson HJ (1996) EPPIC: an evolving system for early detection and optimal management. Schizophr Bull 22(2):305–326

    Article  CAS  PubMed  Google Scholar 

  35. Crumlish N, Whitty P, Clarke M, Browne S, Kamali M, Gerven M, McTigue O, Kinsella A, Waddington JL, Larkin C, O’Callaghan E (2009) Beyond the critical period: longitudinal study of 8-year outcome in non-affective first episode psychosis. Br J Psychiatry 194:18–24

    Article  PubMed  Google Scholar 

  36. Harrigan SM, McGorry PD, Krstev H (2003) Does treatment delay in first-episode psychosis really matter? Psychol Med 33:97–110

    Article  CAS  PubMed  Google Scholar 

  37. Schimmelmann BG, Huber CG, Lambert M, Cotton S, McGorry PD, Conus P (2008) Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort. J Psychiatr Res 42(12):982–990

    Article  PubMed  Google Scholar 

  38. Harris MG, Henry LP, Harrigan SM, Purcell R, Schwartz OS, Farrelly SE, Prosser AL, Jackson HJ, McGorry PD (2005) The relationship between duration of untreated psychosis and outcome: an eight year prospective study. Schizophr Res 79(1):85–93

    Article  PubMed  Google Scholar 

  39. McGlashan T (1996) Early detection and intervention of schizophrenia: research. Schizophr Bull 22:327–345

    Article  CAS  PubMed  Google Scholar 

  40. Power P, Iacoponi E, Reynolds N, Fisher H, Garety PA, McGuire PK, Craig T (2007) The Lambeth Early Onset Crisis Assessment Team Study: general practitioner education and access to an early detection team in first episode psychosis. Br J Psychiatry 191(Supp 51):S133–S139

    Article  Google Scholar 

  41. Lester H, Birchwood M, Freemantle N, Michail M, Tait L (2009) REDIRECT: cluster randomised controlled trial of GP training in first-episode psychosis. Br J Gen Pract 59:e183–e190

    Article  PubMed Central  PubMed  Google Scholar 

  42. Yung AR, Organ BA, Harris MG (2003) Management of early psychosis in a generic adult mental health service. Aust N Z J Psychiatry 37:429–436

    Article  PubMed  Google Scholar 

  43. Krstev H, Carbone S, Harrigan SM, Curry C, Elkin K, McGorry PD (2004) Early intervention in first-episode psychosis: the impact of a community development campaign. Soc Psychiatry Psychiatr Epidemiol 39:711–719

    Article  PubMed  Google Scholar 

  44. Melle I, Larsen TK, Haahr U, Friss S, Johannessen J, Opjordsmoen S, Simonsen E, Rund BR, Vaglum P, McGlashan T (2004) Reducing the duration of untreated first-episode psychosis. Arch Intern Med 61:143–150

    Google Scholar 

  45. Joa I, Johannessen J, Ausestad B, Friis S, McGlashan T, Melle I, Opjordsmoen S, Simonsen E, Vaglum P, Larsen TK (2008) The key to reducing duration of untreated psychosis: information campaigns. Schizophr Bull 34:466–472

    Article  PubMed Central  PubMed  Google Scholar 

  46. Chong SA, Mythily S, Verma S (2005) Reducing the duration of untreated psychosis and changing help-seeking behaviour in Singapore. Soc Psychiatry Psychiatr Epidemiol 40:619–621

    Article  PubMed  Google Scholar 

  47. Malla A, Norman EL, Scholten D, Manchanda R, McLean T (2005) A community intervention for early identification of first-episode psychosis: impact on duration of untreated psychosis (DUP) and patient characteristics. Soc Psychiatry Psychiatr Epidemiol 40:337–344

    Article  PubMed  Google Scholar 

  48. Lloyd-Evans B, Crosby M, Stockton S, Pilling S, Hobbs L, Hinton M, Johnson S (2011) Initiatives to shorten duration of untreated psychosis: systematic review. Br J Psychiatry 198:256–263

    Article  PubMed  Google Scholar 

  49. Melle I, Johannesen JO, Friis S, Haahr U, Joa I, Larsen TK, Opjordsmoen S, Rund BR, Simonsen E, Vaglum MacGlashan TH (2006) Early detection of the first episode of schizophrenia and suicidal behaviour. Am J Psychiatry 163:800–804

    Article  PubMed  Google Scholar 

  50. International Early Psychosis Association Writing Group (2005) International clinical practice guidelines for early psychosis. Br J Psychiatry 187(Supp 48):s120–s124

    Article  Google Scholar 

  51. Lehtinen V, Aaltonen J, Koffett T, Räkköläinen V, Syvälahti E (2000) Two-year outcome in first-episode psychosis treated according to an integrated model. Is immediate neuroleptisation always needed? Eur Psychiatry 15:312–320

    Article  CAS  PubMed  Google Scholar 

  52. Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK (2009) Cardiometabolic risk of second generation antipsychotic medications during first-time use in children and adolescents. JAMA 302:1765–1773

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  53. Britvic D, Maric NP, Doknic M, Pekic S, Andric S, Jasovic-Gasic M, Popovic V (2013) Metabolic issues in psychotic disorders with the focus on first-episode patients: a review. Psychiatr Dunubina 25:410–415

    Google Scholar 

  54. Schultz SC, Thomson R, Brecher M (2003) The efficacy of quetiapine vs haloperidol and placebo: a meta-analytic study of efficacy. Schizophr Res 62:1–12

    Article  Google Scholar 

  55. Arvantis LA, Miller BG (1997) Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group. Biol Psychiatry 42:233–246

    Article  Google Scholar 

  56. Berger G, Proffitt TM, McConchie M, Kerr M, Markulev C, Yuen HP, O’Donnell C, Lubman D, Polari A, Wood SJ, Amminger GP, McGorry PD (2008) Dosing quetiapine in drug-naive first episode psychosis: a controlled, double-blind, randomized, single-centre study investigating efficacy, tolerability and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 years. J Clin Psychiatry 69:1702–1714

    Article  CAS  PubMed  Google Scholar 

  57. McGorry PD, Cocks J, Power P, Burnett P, Harrigan S, Lambert T (2011) Very-low dose risperidone in first-episode psychosis: a safe and effective way to initiate treatment. Schizophr Res Treat 2011:631690

    Google Scholar 

  58. Edwards J, Maude D, McGorry PD, Harrigan SM, Cocks JT (1998) Six-month clinical status as a predictor of 24-month clinical outcome in first-admission patients with schizophrenia. Br J Psychiatry 172:107–116

    CAS  Google Scholar 

  59. Hermann-Doig T, Maude D, Edwards J (2003) Systematic treatment of persistent psychosis (STOPP): a psychological approach to facilitating recovery in young people with first episode psychosis. Martin Dunitz, London

    Google Scholar 

  60. Edwards J, Cocks J, Burnett P, Maud D, Wong L, Yuen HP, Harrigan SM, Hermann-Doig T, Murphy B, Wade D, McGorry PD (2011) Randomized controlled trial of clozapine and CBT for first-episode psychosis with enduring positive symptoms: a pilot study. Schizophr Res Treat 2011:394896

    CAS  Google Scholar 

  61. Berger GE, Smensy S, Amminger GP (2006) Bioactive lipids in schizophrenia. Int Rev Psychiatry 18:85–98

    Article  PubMed  Google Scholar 

  62. Reddy RD, Keshavan MS, Yao JK (2004) Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline. Schizophr Bull 30:901–911

    Article  PubMed  Google Scholar 

  63. Arvindakshan M, Sitasawad S, Debsikdar V, Ghate M, Evans D, Horrobin DF, Bennett C, Ranjekar PK, Mahadik SP (2003) Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients. Biol Psychiatry 53:56–64

    Article  CAS  PubMed  Google Scholar 

  64. Khan MM, Evans DR, Gunna V, Scheffer RE, Parikh W, Mahadik SP (2002) Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never medicated first episode of psychosis and after years of treatments with antipsychotics. Schizophr Res 58:1–10

    Article  PubMed  Google Scholar 

  65. Berger GE, Proffitt TM, McConchie M, Yuen HP, Wood SJ, Amminger GP, Brewer WJ, McGorry PD (2007) Ethyl-eicosapentaenoic acid in first episode psychosis: a randomised, placebo-controlled trial. J Clin Psychiatry 68:1867–1875

    Article  CAS  PubMed  Google Scholar 

  66. McGorry PD, Killackey E, Yung A (2008) Early intervention in psychosis: concepts, evidence and future directions. World Psychiatry 7(3):148–156

    Article  PubMed Central  PubMed  Google Scholar 

  67. Tarrier N, Khan S, Cater J, Picken A (2007) The subjective consequences of suffering a first episode psychosis: trauma and suicide behaviour. Soc Psychiatry Psychiatr Epidemiol 42:29–35

    Article  PubMed  Google Scholar 

  68. Reed SI (2008) First episode psychosis: a literature review. Int J Ment Health Nurs 17:85–91

    Article  PubMed  Google Scholar 

  69. Lieberman JA, Perkins D, Belger A, Chakos M, Jarskog F, Boteva K, Gilmore J (2001) The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiatry 50:884–897

    Article  CAS  PubMed  Google Scholar 

  70. Birchwood M, Todd P, Jackson C (1998) Early intervention in psychosis. The critical period hypothesis. Br J Psychiatry 172(33):53–59

    CAS  Google Scholar 

  71. Penn DL, Waldeter EJ, Perkins DO, Mueser KT, Lieberman JA (2005) Psychosocial treatment for first episode psychosis: a research update. Am J Psychiatry 162:2220–2232

    Article  PubMed  Google Scholar 

  72. Jackson H, McGorry P, Edwards J, Hulbert C, Henry L, Francey S, Maude D, Cocks J, Power P, Harrigan S, Dudgeon P (1998) Cognitively-oriented psychotherapy for early psychosis (COPE): preliminary results. Br J Psychiatry 172:93–100

    CAS  Google Scholar 

  73. Jackson H, McGorry P, Edwards J, Hulbert C (1996) Cognitively oriented psychotherapy for early psychosis (COPE). In: Cotton P, Jackson H (eds) Early intervention and prevention in mental health. Australian Psychological Society, Melbourne, pp 131–154

    Google Scholar 

  74. Jackson H, McGorry P, Edwards J, Hulbert C, Henry L, Harrigan S, Dudgeon P, Francey S, Maude D, Cocks J, Killackey E, Power P (2005) A controlled trial of cognitively oriented psychotherapy for early psychosis (COPE) with four-year follow-up readmission data. Psychol Med 35:1295–1306

    Article  PubMed  Google Scholar 

  75. Jackson HJ, McGorry PD, Killackey E, Bendall S, Allott K, Dudgeon P, Gleeson J, Johnson T, Harrigan S (2008) Acute-phase and 1-year follow-up results of a randomised controlled trial of CBT versus Befriending for first episode psychosis: the ACE project. Psychol Med 38:725–735

    Article  CAS  PubMed  Google Scholar 

  76. Drury V, Birchwood M, Cochrane R, Macmillian F (1996) Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on positive symptoms. Br J Psychiatry 169:593–607

    Article  CAS  PubMed  Google Scholar 

  77. Robinson DG, Woerner MG, Delman HM, Kane JM (2005) Pharmacological treatment for first-episode schizophrenia. Schizophr Bull 31:705–722

    Article  PubMed  Google Scholar 

  78. Wiersma D, Nienhuis FJ, Slooff CJ, Giel R (1998) Natural course of schizophrenic disorders: a 15-year follow-up of a Dutch incidence cohort. Schizophr Bull 24:75–85

    Article  CAS  PubMed  Google Scholar 

  79. Gumley A, O’Grady M, McNay L, Reilly J, Power K, Norrie J (2003) Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy. Psychol Med 33:419–431

    Article  CAS  PubMed  Google Scholar 

  80. Hogarty GE, Greenwald D, Ulrich RF, Kornblith SJ, DiBarry AL, Cooley S, Carter M, Flesher S (1997) Three-year trials of personal therapy among schizophrenic patients living with or independent of family, pt 2: effects of adjustment of patients. Am J Psychiatry 154:1514–1524

    Article  CAS  PubMed  Google Scholar 

  81. Gleeson J, Wade D, Castles D, Gee D, Crisp K, Pearce T, Newman B, Cotton S, Alvarez-Jimenez M, Gilbert M, McGorry P (2008) The Episode II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. J Ment Health 17(1):19–32

    Article  Google Scholar 

  82. Gleeson JFM, Cotton S, Alvarez-Jimenez M, Wade D, Gee D, Crisp K, Newman B, Spiliotacopoulous D, McGorry PD (2009) A randomized controlled trial of CBT for relapse prevention for remitted first-episode psychosis patients. J Clin Psychiatry 70(4):477–486

    Article  PubMed  Google Scholar 

  83. Falloon IRH (1988) Handbook of behavioral family therapy. The Guilford Press, New York

    Google Scholar 

  84. Mueser KT, Glynn SM (1999) Behavioural family therapy for psychiatric disorders. New Harbinger, Oakland

    Google Scholar 

  85. Zhang M, Wang M, Li J, Phillips LR (1994) Randomised-control trial of family intervention for 78 first episode male schizophrenic patients: an 18-month study in Suzhou, Jiangsu. Br J Psychiatry Suppl 165:96–102

    Google Scholar 

  86. Gleeson JFM, Cotton SM, Alvarez-Jimenez M, Wade D, Gee D, Crisp K, Pearce T, Spiliotacopoulos D, Newman B, McGorry PD (2013) A randomised controlled trial of relapse prevention therapy for first episode psychosis patients: outcome at 30-month follow-up. Schizophr Bull 39:436–448

    Article  PubMed Central  PubMed  Google Scholar 

  87. Gleeson JFM, Cotton SM, Alvarez-Jimenez M, Wade D, Crisp K, Newman B, Spiliotacopoulos D, McGorry PD (2010) Family outcomes from an RCT of relapse prevention therapy in first episode psychosis. J Clin Psychiatry 71:475–483

    Article  PubMed  Google Scholar 

  88. Wunderink L, Nieboer RM, Wiersma D, Sytema S, Nienhuis FJ (2013) Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial. JAMA Psychiatry 70:913–920

    Article  PubMed  Google Scholar 

  89. Sacaceno B, Levav I, Kohn R (2005) The public mental health significance of research on socioeconomic factors in schizophrenia and major depression. World Psychiatry 4:181

    Google Scholar 

  90. Lund C, De Silva M, Plagerson S, Cooper S, Chisholm D, Das J, Knapp M, Patel V (2011) Poverty and mental disorders: breaking the cycle in low-income and middle-income countries. Lancet 378:1502–1514

    Article  PubMed  Google Scholar 

  91. Killackey E, Jackson HJ, Gleeson J, Hickie I, McGorry PD (2006) Exciting career opportunity beckons! Early intervention and vocational rehabilitation in first episode psychosis: employing cautious optimism. Aust N Z J Psychiatry 40:951–960

    Article  PubMed  Google Scholar 

  92. Killackey E, Jackson HJ, McGorry PD (2008) Vocational intervention in first episode psychosis: individual placement and support versus treatment as usual. Br J Psychiatry 193:114–120

    Article  PubMed  Google Scholar 

  93. Killackey E, Allott K, Cotton S, Jackson HJ, Scutella R, Tseng Y-P, Borland J, Proffitt TM, Hunt S, Kay-Lambkin F, Chinnery G, Baksheev G, Alvarez-Jimenez M, McGorry PD (2013) A randomized controlled trial of vocational intervention for young people with first-episode psychosis: method. Early Interv Psychiatry 7:329–337

    Article  PubMed  Google Scholar 

  94. Bartholomeusz CF, Allott K (2012) Neurocognitive and social cognitive approaches for improving functional outcome in early psychosis: theoretical considerations and current state of evidence. Schizophr Res Treat 2012:815315

    Google Scholar 

  95. Bartholomeusz CF, Allott K, Killackey E, Liu P, Wood SJ, Thompson A (2013) Social cognition training as an intervention for improving functional outcome in first episode psychosis: a feasibility study. Early Interv Psychiatry 7:421–426

    Article  PubMed  Google Scholar 

  96. Wood SJ, Velakoulis D, Smith DJ, Bond D, Stuart GW, McGorry PD, Brewer WJ, Bridle N, Eritaia J, Desmond P, Singh B, Copolov D, Pantelis C (2001) A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia. Schizophr Res 52:37–46

    Article  CAS  PubMed  Google Scholar 

  97. Takahashi T, Wood SJ, Soulsby B, Kawasaki Y, McGorry PD, Suzuki M, Velakoulis D, Pantelis C (2009) An MRI study of the superior temporal subregions in first-episode patients with various psychotic disorders. Schizophr Res 113:158–166

    Article  PubMed  Google Scholar 

  98. Pariante CM, Vassilopoulou K, Velakoulis D, Phillips L, Soulsby B, Wood SJ, Brewer W, Smith DJ, Dazzan P, Yung AR, Zervas IM, Christodoulou GN, Murray R, McGorry PD, Pantelis C (2004) Pituitary volume in psychosis. Br J Psychiatry 185:5–10

    Article  PubMed  Google Scholar 

  99. Brewer WJ, Wood SJ, McGorry PD, Francey SM, Phillips LJ, Yung AR, Anderson V, Copolov DL, Singh B, Velakoulis D, Pantelis C (2001) Stability of olfactory identification deficits in neuroleptic-naive patients with first-episode psychosis. Am J Psychiatry 158:107–115

    Article  CAS  PubMed  Google Scholar 

  100. Mathes B, Wood SJ, Proffitt TM, Stuart GW, Buchanan JA, Velakoulis D, Brewer WJ, McGorry PD, Pantelis C (2005) Early processing deficits in object working memory in first-episode schizophreniform psychosis and established schizophrenia. Psychol Med 35:1053–1062

    Article  PubMed  Google Scholar 

  101. Wood SJ, Tarnawski AU, Proffitt TM, Brewer WJ, Savage GR, Anderson V, McGorry PD, Velakoulis D, Pantelis C (2007) Fractionation of verbal memory impairment in schizophrenia and schizophreniform psychosis. Aust N Z J Psychiatry 41:732–739

    Article  PubMed  Google Scholar 

  102. Bartholomeusz CF, Proffitt TM, Savage G, Simpson L, Markulev C, Kerr M, McConchie M, McGorry PD, Pantelis C, Berger GE, Wood SJ (2011) Relational memory in first episode psychosis: implications for progressive hippocampal dysfunction after illness onset. Aust N Z J Psychiatry 45:206–213

    Article  PubMed  Google Scholar 

  103. Takahashi T, Wood SJ, Soulsby B, McGorry PD, Tanino R, Suzuki M, Velakoulis D, Pantelis C (2009) Follow-up MRI study of the insular cortex in first-episode psychosis and chronic schizophrenia. Schizophr Res 108:49–56

    Article  PubMed  Google Scholar 

  104. Fornito A, Yücel M, Wood SJ, Adamson C, Velakoulis D, Saling MM, McGorry PD, Pantelis C (2008) Surface-based morphometry of the anterior cingulate cortex in first episode schizophrenia. Hum Brain Mapp 29:478–489

    Article  PubMed  Google Scholar 

  105. Walterfang M, Wood AG, Reutens DC, Wood SJ, Chen J, Velakoulis D, McGorry PD, Pantelis C (2008) Morphology of the corpus callosum at different stages of schizophrenia: cross-sectional study in first-episode and chronic illness. Br J Psychiatry 192:429–434

    Article  PubMed  Google Scholar 

  106. Sun D, Stuart GW, Jenkinson M, Wood SJ, McGorry PD, Velakoulis D, van Erp TG, Thompson PM, Toga AW, Smith DJ, Cannon TD, Pantelis C (2009) Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Mol Psychiatry 14:976–986

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  107. Velakoulis D, Wood SJ, McGorry PD, Pantelis C (2000) Evidence for progression of brain structural abnormalities in schizophrenia: beyond the neurodevelopmental model. Aust N Z J Psychiatry 34:S113–S126

    Article  PubMed  Google Scholar 

  108. Velakoulis D, Wood SJ, Wong MT, McGorry PD, Yung A, Phillips L, Smith D, Brewer W, Proffitt T, Desmond P, Pantelis C (2006) Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch Gen Psychiatry 63:139–149

    Article  PubMed  Google Scholar 

  109. Wood SJ, Proffitt TM, Mahony K, Smith DJ, Buchanan JA, Brewer WJ, Stuart GW, Velakoulis D, McGorry PD, Pantelis C (2002) Visuospatial memory and learning in first-episode schizophreniform psychosis and established schizophrenia: a functional correlate of hippocampal pathology? Psychol Med 32:429–438

    Article  CAS  PubMed  Google Scholar 

  110. Harrison BJ, Yücel M, Shaw M, Brewer WJ, Nathan PJ, Strother SC, Olver JS, Egan GF, Velakoulis D, McGorry PD, Pantelis C (2006) Dysfunction of dorsolateral prefrontal cortex in antipsychotic-naïve schizophreniform psychosis. Psychiatry Res Neuroimaging 148:23–31

    Article  PubMed  Google Scholar 

  111. Yücel M, Brewer WJ, Harrison BJ, Fornito A, O’Keefe GJ, Olver J, Scott AM, Egan GF, Velakoulis D, McGorry PD, Pantelis C (2007) Anterior cingulate activation in antipsychotic-naive first-episode schizophrenia. Acta Psychiatr Scand 115:155–158

    Article  PubMed  Google Scholar 

  112. Cocchi L, Walterfang M, Testa R, Wood SJ, Seal ML, Suckling J, Takahashi T, Proffitt TM, Brewer WJ, Adamson C, Soulsby B, Velakoulis D, McGorry PD, Pantelis C (2009) Grey and white matter abnormalities are associated with impaired spatial working memory ability in first-episode schizophrenia. Schizophr Res 115:163–172

    Article  PubMed  Google Scholar 

  113. Nicolo JP, Berger GE, Garner BA, Velakoulis D, Markulev C, Kerr M, McGorry P, Proffitt TM, McConchie M, Pantelis C, Wood SJ (2010) The effect of atypical antipsychotics on pituitary gland volume in patients with first-episode psychosis: a longitudinal MRI study. Schizophr Res 116:49–54

    Article  PubMed  Google Scholar 

  114. Brewer WJ, Yücel M, Harrison BJ, McGorry PD, Oliver J, Egan GF, Velakoulis D, Pantelis C (2007) Increased prefrontal cerebral blood flow in first-episode schizophrenia following treatment: longitudinal positron emission tomography study. Aust N Z J Psychiatry 41:129–135

    Article  PubMed  Google Scholar 

  115. Wood SJ, Berger GE, Wellard RM, Proffitt T, McConchie M, Velakoulis D, McGorry PD, Pantelis C (2008) A 1H-MRS investigation of the medial temporal lobe in antipsychotic-naïve and early-treated first episode psychosis. Schizophr Res 102:163–170

    Article  PubMed  Google Scholar 

  116. Murphy BP, Pang TY, Hannan AJ, Proffitt TM, McConchie M, Kerr M, Markulev C, O’Donnell C, McGorry PD, Berger GE (2014) Vascular endothelial growth factor and brain-derived neurotrophic factor in quetiapine treated first-episode psychosis. Schizophr Res Treat 2014:719395

    Google Scholar 

  117. Berger G, Wood SJ, Wellard RW, Proffitt TM, McConchie M, Amminger GP, Jackson GD, Velakoulis D, Pantelis C, McGorry PD (2008) Ethyl-eicosapentaenoic acid in first episode psychosis. A 1H-MRS study. Neuropsychopharmacology 33:2467–2473

    Article  CAS  PubMed  Google Scholar 

  118. Wood SJ, Cocchi L, Proffitt TM, McConchie M, Jackson GD, Takahashi T, Pantelis C, McGorry P, Berger GE (2010) Neuroprotective effects of ethyl-eicosapentaenoic acid in first episode psychosis: a longitudinal T2 relaxometry pilot study. Psychiatry Res Neuroimaging 182:180–182

    Article  CAS  PubMed  Google Scholar 

  119. Pantelis C, Yücel M, Wood SJ, McGorry PD, Velakoulis D (2003) Early and late neurodevelopmental disturbances in schizophrenia and their functional consequences. Aust N Z J Psychiatry 37:399–406

    Article  PubMed  Google Scholar 

  120. Pantelis C, Wood SJ, Proffitt TM, Mahony K, Brewer WJ, Buchanan JA, Velakoulis D, McGorry PD (2009) Attentional set-shifting ability in first-episode and established schizophrenia: relationship to working memory. Schizophr Res 112:104–113

    Article  PubMed  Google Scholar 

  121. Phillips LJ, McGorry PD, Garner B, Thompson KN, Pantelis C, Wood SJ, Berger G (2006) Stress, the hippocampus and the hypothalamic–pituitary–adrenal axis: implications for the development of psychotic disorders. Aust N Z J Psychiatry 40:725–741

    Article  PubMed  Google Scholar 

  122. McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ (2006) Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry 40:616–622

    Article  PubMed  Google Scholar 

  123. McGorry PD, Nelson B, Goldstone S, Yung AR (2010) Clinical staging: a heuristic and practical strategy for new research and better health and social outcomes for psychotic and related mood disorders. Can J Psychiatry 55:486–497

    PubMed  Google Scholar 

  124. Scott J, Leboyer M, Hickie I, Berk M, Kapczinski F, Frank E, Kupfer D, McGorry P (2013) Clinical staging in psychiatry: a cross-cutting model of diagnosis with heuristic and practical value. Br J Psychiatry 202:243–245

    Article  PubMed  Google Scholar 

  125. McGorry PD, Yung A, Phillips L (2001) Ethics and early intervention in psychosis: keeping up the pace and staying in step. Schizophr Res 51:17–29

    Article  CAS  PubMed  Google Scholar 

  126. Simon AE, Velthorst E, Nieman DH, Linszen D, Umbricht D, de Haan L (2011) Ultra high-risk state for psychosis and non-transition: a systematic review. Schizophr Res 132:8–17

    Article  PubMed  Google Scholar 

  127. McGorry PD (2002) Consensus on early intervention in schizophrenia. Schizophr Bull 132:8–17

    Google Scholar 

  128. Francey SM, Nelson B, Thompson A, Parker AG, Kerr M, Macneil C, Fraser R, Hughes F, Crisp K, Harrigan S, Wood SJ, Berk M, McGorry PD (2010) Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention. Schizophr Res 119:1–10

    Article  CAS  PubMed  Google Scholar 

  129. Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Judd F, Katz F, Katz P, Ording-Jespersen S, Little J, Conus P, Cuenod M, Do KQ, Bush AI (2008) N-acetyl cysteine as a glutathione precursor for schizophrenia–a double-blind, randomized, placebo-controlled trial. Biol Psychiatry 64:361–368

    Article  CAS  PubMed  Google Scholar 

  130. Iseger TA, Bossong MG (2015) A systematic review of the antipsychotic properties of cannabidiol in humans. Schizophr Res 162:153–161

    Article  PubMed  Google Scholar 

  131. Penn D, Waldeter EJ, Perkins DO, Mueser KT, Lieberman JA (2005) Psychosocial treatment for first-episode psychosis: a research update. Am J Psychiatry 162:2220–2232

    Article  PubMed  Google Scholar 

  132. Jackson H, McGorry P, Henry L, Edwards J, Hulbert C, Harrigan S, Dudgeon P, Francey S, Maude D, Cocks J, Power P (2001) Cognitively oriented psychotherapy for early psychosis (COPE): a 1-year follow-up. Br J Clin Psychol 40:57–70

    Article  CAS  PubMed  Google Scholar 

  133. Gleeson J, Wade D, Albiston D, Castle D, Gilbert M, Gee D, Crisp K, Pearce T, Newman B, Cotton S, Young D, McGorry P (2005) Preventing EPISODE II: relapse prevention n first-episode psychosis. Australias Psychiatry 13:384–387

    Article  Google Scholar 

  134. Stavely H, Hughes F, Pennell K, McGorry PD, Purcell R (2013) EPPIC model implementation guide. Orygen Youth Health Research Centre, Melbourne

    Google Scholar 

  135. Alvarez-Jimenez M, Bendall S, Lederman R, Wadley G, Chinnery G, Vargas S, Larkin M, Killackey E, McGorry PD, Gleeson JF (2013) On the HORYZON: moderated online social therapy for long-term recovery in first episode psychosis. Schizophr Res 143:143–149

    Article  CAS  PubMed  Google Scholar 

  136. Birchwood M, Fiorillo A (2000) The critical period for early intervention. Psychiatr Rehabil Skills 4:182–198

    Article  Google Scholar 

  137. Purcell R, Goldstone S, Moran J, Albiston D, Edwards J, Pennell K, McGorry PD (2011) Toward a twenty-first century approach to youth mental health care. Int J Ment Health 40:72–87

    Article  Google Scholar 

  138. Kane JM, Schooler NR, Marcy P, Correll CU, Brunette MF, Mueser KT, Rosenheck R, Addington J, Estroff SE, Robinson J, Penn DL, Robinson DG (2015) The RAISE early treatment program for first-episode psychosis: background, rationale, and study design. J Clin Psychiatry 76:240–246

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. M. Cotton.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cotton, S.M., Filia, K.M., Ratheesh, A. et al. Early psychosis research at Orygen, The National Centre of Excellence in Youth Mental Health. Soc Psychiatry Psychiatr Epidemiol 51, 1–13 (2016). https://doi.org/10.1007/s00127-015-1140-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00127-015-1140-0

Keywords

Navigation